Sort
4,870 grants matching “glp 1”
De-risking ONL1204 to enable venture capital investment for first-in-human clinical trials
$219,861Jana Van De Goor · Onl Therapeutics, Inc. · SB1 · FY2018 · EY
Liver Glycogen in Control of Plasma Glucose
$219,664Katarina T Borer · University Of Michigan At Ann Arbor · R15 · FY2009 · DK
Regulation of Food Intake and Body Weight by GLP-1
$219,568Roger Reidelberger · Creighton University · R01 · FY2008 · DK
A New Approach to Compute PM2.5 for Health Impact Analysis
$219,458Fazlay S Faruque · University Of Mississippi Med Ctr · R21 · FY2011 · ES
SURGERY AND INTESTINAL ADAPTATION
$219,216Brigham And Women'S Hospital · R01 · FY2001 · DK
Clinical Translation of Near Infrared Nerve-Specific Fluorophores for Nerve-sparing Prostatectomy
$218,995Connor William Barth · Inherent Targeting, Llc · R44 · FY2022 · CA
Regulation of Food Intake and Body Weight by GLP-1
$218,920Roger Reidelberger · Creighton University · R01 · FY2009 · DK
Discovery of biased small molecule agonists of the GLP-1 receptor for treatment o
$218,895Johan Karl Enquist · Carmot Therapeutics, Inc. · R43 · FY2013 · DK
Rapid Magnetomotive Thrombolysis for Stroke
$218,751Francis Milton Creighton · Pulse Therapeutics, Inc. · R44 · FY2014 · NS
Small Molecule Anti-Inflammatories for Ocular Graft Versus Host Disease
$218,692Victor L Perez · Eyedesis Biosciences, Llc · R41 · FY2018 · EY
Bioanalytical Core
$218,603Pedro A. Jose · Children'S Research Institute · U54 · FY2011 · HD
Modulation of cancer induced immune suppression via inhibition of SCD1
$217,685Karen E Hayes · Modulation Therapeutics, Inc. · R44 · FY2025 · CA
BPA as a Developmental Carcinogen
$217,646Ana Soto · Tufts University Boston · U01 · FY2013 · ES
Small Animal Phenotyping Core
$217,500Barbara A. Gower · University Of Alabama At Birmingham · P30 · FY2010 · DK
HDAC2 Inhibitors for the Treatment of Cognitive Deficits in Alzheimer's Disease
$217,210Martin R Jefson · Rodin Therapeutics, Inc. · R43 · FY2015 · AG
GLP-1 IN NORMAL AND ABNORMAL GLUCOSE TOLERANCE
$217,021University Of Cincinnati · R01 · FY2001 · DK
Metabolic effects of non-nutritive sweeteners
$216,254Kristina Rother · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Regulation of Food Intake and Body Weight by GLP-1
$216,114Roger Reidelberger · Creighton University · R01 · FY2010 · DK
TOTAL PARENTERAL NUTRITION AND INTESTINAL ADAPTION
$216,000University Of Wisconsin Madison · R01 · FY2003 · DK
TOTAL PARENTERAL NUTRITION AND INTESTINAL ADAPTION
$216,000University Of Wisconsin Madison · R01 · FY2002 · DK
Oral Small Molecule STAT3 Inhibitor to Treat Cachexia in Chronic Kidney Disease
$215,557David John Tweardy · Stemmed, Ltd · R42 · FY2016 · DK
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
$215,359Chee W Chia · National Institute On Aging · ZIA · FY2017 · AG
Multi-Modal Mechanisms of Novel Sulfated Non Anticoagulant Heparin inSickle Cell Disease Management
$215,058Shaker A Mousa · Vascular Vision Pharmaceuticals Company · R41 · FY2019 · HL
Mucus Penetrating Nanoparticles for Small Cell Lung Cancer
$214,864Justin S. Hanes · Johns Hopkins University · U54 · FY2010 · CA
Thiol-Ene Click Hydrogels for in situ Cell Expansion and Differentiation
$214,800Chien-Chi Lin · Indiana University Indianapolis · R21 · FY2011 · EB